Showing results (21-30 of 6,696) with videos related to

Sort By:
Pageof 670
Heart (British Cardiac Society)|April 12, 2022
Predicting outcome after cardiac resynchronisation therapy defibrillator implantation: the cardiac resynchronisation therapy defibrillator Futility scoreBaptiste Maille, Alexandre Bodin, Arnaud Bisson, et al.
Heart (British Cardiac Society)|April 14, 2022
Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid populationSimone Marschner, Amy von Huben, Sarah Zaman, et al.
Heart (British Cardiac Society)|June 2, 2019
NT-proBNP, race and endothelial function in the Multi-Ethnic Study of AtherosclerosisSushan Yang, Shi Huang, Lori B Daniels, et al.
Heart (British Cardiac Society)|July 26, 2022
Long-term outcomes in distinct phenogroups of patients with primary mitral regurgitation undergoing valve surgerySoongu Kwak, Seung-Ah Lee, Jaehyun Lim, et al.
Heart (British Cardiac Society)|June 30, 2010
Reduced left atrial function on exercise in patients with heart failure and normal ejection fractionY T Tan, F Wenzelburger, E Lee, et al.
Heart (British Cardiac Society)|May 22, 2010
Individualising the risks of statins in men and women in England and Wales: population-based cohort studyJulia Hippisley-Cox, Carol Coupland
Heart (British Cardiac Society)|October 22, 2010
Diesel exhaust inhalation does not affect heart rhythm or heart rate variabilityNicholas L Mills, Alexander E Finlayson, Manuel C Gonzalez, et al.
Heart (British Cardiac Society)|October 22, 2010
Long-term prognostic value of left ventricular dyssynchrony assessment by phase analysis from myocardial perfusion imagingAju P Pazhenkottil, Ronny R Buechel, Lars Husmann, et al.
Heart (British Cardiac Society)|October 23, 2010
Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI registerNicolas Danchin, Laurent Fauchier, Eloi Marijon, et al.
Heart (British Cardiac Society)|October 20, 2010
Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?Timothy D Warner, Paul C J Armstrong, Nicholas P Curzen, et al.
Pageof 670